Literature DB >> 16112720

Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects.

Thomas F Newton1, Richard De La Garza, Ari D Kalechstein, Liam Nestor.   

Abstract

The stimulant effects of cocaine and methamphetamine are mediated by changes in synaptic concentrations of brain monoamines; however, the drugs alter monoamine levels via different mechanisms. This study examined the subjective and cardiovascular responses produced by investigational administration of cocaine or methamphetamine, in order to examine the onset and patterns of subjective and cardiovascular responses. Subjects included 14 non-treatment seeking cocaine-dependent and 11 non-treatment seeking methamphetamine-dependent volunteers. As part of ongoing research studies, cocaine and methamphetamine subjects received cocaine (40 mg, IV) or methamphetamine (30 mg, IV), respectively. Subjective and cardiovascular responses were assessed for 30 min and 60 min, respectively. The data reveal significant within groups differences for all subjective effects and cardiovascular effects (p<0.05). Significant between group differences in subjective effects were observed for "Any Drug Effect" (p<.008 for group, and p<.029 for group x time), for "High" (p<.002 for group, and p<.0001 for group x time) and for "Stimulated" (p<.001 for group, and p<.006 for group x time). Significant between group differences in cardiovascular effects were observed for Systolic blood pressure (p<.0001 for group, and p<.002 for group x time), Diastolic blood pressure (p<.0001 for group, though p=NS for group x time), and for Heart Rate (p<.0001 for group, and p<.0001 for group x time). The only difference between the groups for placebo was for heart rate, where there was a significant group x time effect (p<.005). Taken together, the data reveal that the subjective effects of cocaine tended to peak and then decline more rapidly than those produced by methamphetamine. The subjective effects of methamphetamine tended to rise more slowly, and remain elevated longer. Cardiovascular effects of cocaine and methamphetamine had similar onset, but effects of cocaine tended to decline more rapidly. Overall, the results reveal differences in the onset, pattern, and duration of subjective and cardiovascular responses following cocaine or methamphetamine administration in stimulant addicted patients. We predict that these differences may impact drug use and relapse patterns, and may have implications in medications development for these addictive disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112720     DOI: 10.1016/j.pbb.2005.07.012

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  40 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine.

Authors:  Noah R Gubner; Cheryl Reed; Carrie S McKinnon; Tamara J Phillips
Journal:  Behav Brain Res       Date:  2013-08-28       Impact factor: 3.332

3.  Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire.

Authors:  R Z Goldstein; P A Woicik; S J Moeller; F Telang; M Jayne; C Wong; G J Wang; J S Fowler; N D Volkow
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

4.  Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment.

Authors:  Theresa M Winhusen; Frankie Kropp; Jeff Theobald; Daniel F Lewis
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

5.  The effects of cocaine on heart rate and electrocardiogram in zebrafish (Danio rerio).

Authors:  Erik J Mersereau; Shelby L Poitra; Ana Espinoza; Dane A Crossley; Tristan Darland
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-04-03       Impact factor: 3.228

6.  Correlates of nonmedical use of stimulants and methamphetamine use in a national sample.

Authors:  Lian-Yu Chen; Eric C Strain; Pierre Kébreau Alexandre; G Caleb Alexander; Ramin Mojtabai; Silvia S Martins
Journal:  Addict Behav       Date:  2014-02-12       Impact factor: 3.913

7.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

8.  The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

Authors:  R De La Garza; J J Mahoney; C Culbertson; S Shoptaw; T F Newton
Journal:  Pharmacol Biochem Behav       Date:  2008-01-22       Impact factor: 3.533

9.  Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition.

Authors:  Beau Abar; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Lynne M Smith; Amelia Arria; Marilyn Huestis; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  Psychol Addict Behav       Date:  2012-10-15

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.